Calidi Biotherapeutics, Inc. (NYSE:CLDI) appears in 24 institutional 13F filings for the quarter ending June 2026.
| # | Institution | CIK | Shares Held | % of Outstanding | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 0001214717 | 7,159 | 0.51% | ▲3,221 | +81.77% | $19.47K |
| 2 | HighTower Advisors, LLC | 0001462245 | 5,220 | 0.37% | 0 | 0.00% | $14.20K |
| 3 | JANE STREET GROUP, LLC | 0001595888 | 3,392 | 0.24% | ▲1,217 | +55.95% | $9.23K |
| 4 | Independent Advisor Alliance | 0001696899 | 2,813 | 0.20% | ▲2,813 | 0.00% | $7.65K |
| 5 | RS CRUM INC. | 0001401459 | 2,702 | 0.19% | ▲186 | +7.41% | $7.35K |
| 6 | Arax Advisory Partners | 0001586767 | 2,334 | 0.16% | 0 | 0.00% | $6.35K |
| 7 | Private Advisor Group, LLC | 0001567755 | 1,875 | 0.13% | ▲1,875 | 0.00% | $5.10K |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 0002100119 | 1,594 | 0.11% | 0 | 0.00% | $4.34K |
| 9 | Belpointe Asset Management LLC | 0001721242 | 1,245 | 0.09% | 0 | 0.00% | $3.39K |
| 10 | Northern Trust Corp | 0000073124 | 1,110 | 0.08% | 0 | 0.00% | $3.02K |
| 11 | Morgan Stanley | 0000895421 | 828 | 0.06% | ▲236 | +39.90% | $2.25K |
| 12 | RFG Advisory, LLC | 0001633387 | 750 | 0.05% | ▲750 | 0.00% | $2.04K |
| 13 | Farther Finance Advisors, LLC | 0001992825 | 625 | 0.04% | 0 | 0.00% | $1.70K |
| 14 | UBS Group AG | 0001610520 | 493 | 0.03% | ▲493 | 0.00% | $1.34K |
| 15 | Citigroup Inc | 0000831001 | 287 | 0.02% | ▲286 | +32,714.29% | $781 |
| 16 | OSAIC HOLDINGS, INC. | 0001677044 | 166 | 0.01% | ▲34 | +25.83% | $450 |
| 17 | Tower Research Capital LLC (TRC) | 0001533421 | 87 | 0.01% | 0 | 0.00% | $237 |
| 18 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0000919185 | 65 | 0.00% | 0 | 0.00% | $177 |
| 18 | Finepoint Capital LP | 0001608126 | 65 | 0.00% | 0 | 0.00% | $177 |
| 19 | SBI Securities Co., Ltd. | 0001851815 | 23 | 0.00% | ▲16 | +226.09% | $64 |